September 4th 2024
Prevent Blindness is planning a series of events and program partnerships leading up to World Sight Day on Oct. 10, 2024.
Modern-izing Retina
September 4 - 5, 2024
View More
Medical Crossfire®: Considerations for the Use of Biosimilars in Retinal Disease - Are You Prepared for a New Paradigm? (CME Credit)
View More
Community Practice Connections™: Novel Treatment Strategies in the Management of nAMD & DME - Lessons from Clinical Trial and Real-World Data
View More
Medical Crossfire®: Expert Insights in Anti-VEGF Dosing for nAMD and DME – Optimizing Reduction in Treatment Burden
View More
Medical Crossfire®: Considerations for the Use of Biosimilars in Retinal Disease - Are You Prepared for a New Paradigm? (COPE Credit)
View More
EyeCon 2024
September 27-28, 2024
Register Now!
Going to AAO? Join Us for Free CME In-Person or Virtually
October 18-19, 2024
Register Now!
(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (CME/CNE Credit)
View More
Community Practice Connections™: Mastering the Multidisciplinary Management of Glaucoma—Understanding Advances in the Spectrum of Treatment Innovation (COPE Credit)
View More
(COPE) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Advancing Treatment in Neovascular Retinal Disease with Novel Therapies: Insights and Strategies from Latest Real-World and Clinical Data
View More
Rapid Reviews in Retina™: Emerging Updates from Fall 2023 – Addressing the Wealth of New Data in Treatments for nAMD and DME
View More
(CME) Stratifying the Spectrum of Care in Glaucoma Management – Advancing Treatment with a Vast Armamentarium
View More
(COPE) Community Practice Connections™: Optimizing Multidisciplinary Care for nAMD & DME – Expert Perspectives with New Dosing Strategies on the Horizon
View More
(CME) Community Practice Connections™: Advancing Management Strategies in Geographic Atrophy– Mapping Out the Continuum of Care in a New Era of Transformative Treatment
View More
(COPE) Community Practice Connections™: Advancing Management Strategies in Geographic Atrophy– Mapping Out the Continuum of Care in a New Era of Transformative Treatment
View More
(COPE) Key Advances in Cataract Surgery – Applications for New Technologies in an Ever-Changing Landscape
View More
(CME) Key Advances in Cataract Surgery – Applications for New Technologies in an Ever-Changing Landscape
View More
(CME) Community Practice Connections™: Optimizing Multidisciplinary Care for nAMD & DME – Expert Perspectives with New Dosing Strategies on the Horizon
View More
Managing Ocular Toxicities in Patients With Cancer: Understanding ADCs and the ECP’s Role in Collaborative Management Therapy on the Horizon (CME Credit)
View More
Managing Ocular Toxicities in Patients With Cancer: Understanding ADCs and the ECP’s Role in Collaborative Management Therapy on the Horizon (COPE Credit)
View More
SimulatED™: Applying Advanced Treatment for nAMD & DME - Simulating New Strategies for Clinical Management
View More
Navigating the Advances in the Treatment of Geographic Atrophy: Updates and Strategies for Managed Care
View More
Rapid Reviews in Retina™: Emerging Updates from Winter 2024 – Addressing the Wealth of New Data in Treatments for nAMD and DME (CME Track)
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (CME Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (CME Track)
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (COPE Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (CME Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (COPE Track)
View More
Signs of pellucid marginal degeneration should rule out refractive surgery
November 10th 2006Pellucid marginal degeneration is a subtle condition that could lead to corneal ectasia following laser eye surgery. Although it is atypical and rare, clinicians should learn how to identify pellucid and screen patients for it preoperatively, said Yaron S. Rabinowitz, MD, director of ophthalmology research, Cedars Sinai Medical Center, Los Angeles.
Read More
Sealed capsule irrigation device helps prevent PCO development in small eyes
November 1st 2006Stockholm, Sweden-The Perfect Capsule (Milvella), a sealed capsule irrigation device, seems to be very useful in very small eyes for preventing posterior capsular opacification (PCO), according to Maria Kugelberg, MD, PhD.
Read More
FDA approves B&L plasma treatment of GP contact lenses
October 15th 2006Las Vegas-Bausch & Lomb has received U.S. FDA approval to add a cold oxygen plasma treatment to the manufacturing process of gas permeable (GP) contact lenses made with Boston materials. B&L made the announcement recently at the American Optometric Association Congress and Annual American Optometric Student Association Conference.
Read More
Safety favorable with pediatric primary IOL implantation
October 15th 2006Charleston, SC-Pediatric cataract surgery with IOL implantation and primary posterior capsulectomy plus vitrectomy is associated with a satisfactory outcome, especially in children operated on after their first birthday, said Rupal H. Trivedi, MD, MSCR.
Read More
Boston's Dr. Grosskreutz awarded glaucoma prize
October 1st 2006New York-Cynthia L. Grosskreutz, MD, PhD, co-director of Glaucoma Service, Massachusetts Eye and Ear Infirmary, Boston, and assistant professor of ophthalmology, Harvard Medical School, Boston, received the New York Academy of Medicine's 2006 Lewis Rudini Glaucoma Prize for the discovery of an enzyme that contributes to nerve cell death in the eye in glaucoma.
Read More
Remote imaging system increases doctor's reach to premature infants
September 15th 2006Palo Alto, CA-Darius Moshfeghi, MD, pediatric retina specialist at Lucile Packard Children's Hospital, Palo Alto, CA, and one of just a few physicians in California's Bay Area trained to diagnose retinopathy of prematurity (ROP), is using technology to bring his expertise to premature babies without having to travel to see them.
Read More
FDA approves B&L plasma treatment of GP contact lenses
September 15th 2006Las Vegas-Bausch & Lomb has received U.S. FDA approval to add a cold oxygen plasma treatment to the manufacturing process of gas-permeable (GP) contact lenses made with Boston materials. B&L made the announcement recently at the American Optometric Association Congress and Annual American Optometric Student Association Conference.
Read More
Children's reading problems can be complicated to decipher
September 15th 2006La Jolla, CA-Screening for problems that affect school performance can be a challenge, according to David B. Granet, MD, who posed the question: "Who evaluates whether patients understand what they see?" Dr. Granet explained the task of pediatric ophthalmologists.
Read More
Should IOP be adjusted for corneal thickness alone?
September 15th 2006While the Goldmann applanation tonometer is a very accurate instrument for measuring IOP compared with previous instruments, ophthalmologists now know that central corneal thickness (CCT) is much more variable than was believed when the instrument was developed.
Read More
Coming home in the evening, I sometimes feel compelled to share with my daughter and spouse something I learned at work that day. This is always a mistake. Invariably my wisdom is greeted with a quick retort from my teenage daughter: "Dad, stop talking." My darling wife and love of my life is more generous; after expressing interest and asking a few questions, she tells me where I have gone wrong. Sometimes this results in an argument, as it did on this evening.
Read More
Book helps kids prepare for eye surgery
August 15th 2006As a pediatric ophthalmologist, Mark Silverberg, MD, relies on special tactics and tools to make his young patients feel at ease. Dr. Silverberg is pleased to have a new book to share with kids and their families that tells the story of eye surgery from a child's perspective, in simple terms with illustrative photographs.
Read More
Pediatric ocular allergy can be alleviated
August 15th 2006Chicago-High allergen counts this season combined with increased parental awareness about the potential functional impact of allergic conjunctivitis are leading to an increase in the number of pediatric patients being seen for control of ocular allergy.
Read More
Long-acting azithromycin safe, effective in treating bacterial conjunctivitis
July 15th 2006Fort Lauderdale, FL-An investigational longacting solution of 1.0% azithromycin (AzaSite, InSite Vision) is safe, well tolerated, and effective for the treatment of bacterial conjunctivitis in pediatric patients and adults, according to the results of pivotal phase III clinical trial involving placebo and active controls.
Read More
ECP at time of phaco effectively lowers IOP
July 15th 2006I have been using endoscopic cyclophotocoagulation (ECP) to treat patients with cataract and medically controlled glaucoma for 5 1/2 years and have found it to be a very useful addition to my armamentarium. The procedure is particularly attractive as an adjunct to small-incision cataract surgery. It takes only about 5 to 10 extra minutes to add ECP to phacoemulsification.
Read More
UCLA's Dr. Demer named to Leonard Apt endowed chair
June 15th 2006Los Angeles-Joseph L. Demer, MD, PhD, a noted authority on extraocular muscle movement, has been named the first holder of the Leonard Apt Endowed Chair in Pediatric Ophthalmology at the Jules Stein Eye Institute at the University of California, Los Angeles (UCLA).
Read More
Proposals given for ROP detection and treatment
June 15th 2006San Francisco-The American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, and American Academy of Pediatrics released a series of recommendations on which to base effective detection and treatment of retinopathy of prematurity (ROP). The groups discuss improvements in the possible treatment of ROP and the importance of carefully timed retinal exams by an ophthalmologist for at-risk premature infants.
Read More
Essilor now offers Definity lenses nationwide
May 15th 2006Dallas-Essilor of America Inc. now offers Definityprogressive lenses through its network of laboratories and otherselect labs nationwide. Definity lenses feature Dual Add, apatented technology that maximizes available design space of thelens, minimizing peripheral distortion and providing a smoothertransition between all distances.
Read More
Pediatric vision screening worthy of advocacy
May 1st 2006Sacramento, CA-Obtaining reimbursement and resources forvision screening seems to be a thankless task with little return.However, there are strategies that can be used to give pediatricvision screening a fair share of the available health-care funds,according to James Bradford Ruben, MD.
Read More
Vision screening standardization recommended
April 15th 2006Portland, OR?Mass vision screening of school-age children was first recommended in 1983. At that time there was not a large population of children of preschool age, a situation that has changed markedly since then because today many more 3- and 4-year-olds are in a preschool setting. However, there is still no standardization in vision screening.
Read More
Screenings for amblyopia should be standardized
April 15th 2006Madison, WI - Uniform testing and reporting criteria are needed toidentify amblyogenic risk factors in children and prevent thedevelopment of amblyopia. Leslie W. France, CO, described theevidence base for the guidelines to detect amblyogenic riskfactors.
Read More
Corticosteroid provides potent, safe ocular allergy control
April 1st 2006Experience from clinical trials and daily clinical practice indicate that loteprednol etabonate 0.2% (Alrex, Bausch & Lomb) is a valuable therapeutic option for both short- and longer-term management of allergic conjunctivitis, according to ophthalmologists who have studied and used this novel anti-inflammatory corticosteroid agent.
Read More
Pretreat eye allergies for better surgical results
April 1st 2006Dorado, Puerto Rico?Patients with allergies should be identified and treated before undergoing ophthalmic surgery in order to improve healing for optimal visual outcomes, explained Francis S. Mah, MD, who spoke during the Current Concepts in Ophthalmology meeting in Dorado, Puerto Rico.
Read More